For the Inventor, By the Inventor

Enter assignee name

Portland, OR, United States of America

Tricol Biomedical, Inc.

USPTO Granted Patents = 14

EPO Patents = 3

Trademarks = 12

Forward Citations = 36

Loading Chart...

Loading Chart...

18 inventors (with patents filed for the assignee):

Simon J McCarthy (14 out of 29 patents)

Sam Kuhn (9 out of 9 patents)

Barbara McGrath (8 out of 9 patents)

4. Michael Stolten (8 out of 8 patents)

5. Amanda Bennett (8 out of 8 patents)

6. Alysha Wold (5 out of 5 patents)

7. Jess Kimball (3 out of 4 patents)

8. Hua Xie (3 out of 8 patents)

9. Mattie R Jones (3 out of 3 patents)

10. Maggie Bush (1 out of 1 patent)

11. Brintha Enestvedt (1 out of 1 patent)

12. Kenneth P Perry (1 out of 1 patent)

13. Kenneth E Perry (1 out of 8 patents)

14. Ervelyn Winata (1 out of 1 patent)

15. Cole Gannett (1 out of 1 patent)

14 patents: Sort by Forward Citations

1. 12508171 - Delivery systems for control of bleeding in transurethral prostatectomy (2025-12-30),

2. 12156791 - Chitosan dressing for control of bleeding in transurethral prostatectomy (2024-12-03),

3. 11890384 - Chitosan superfine fiber systems (2024-02-06),

4. 11660236 - Delivery systems for control of bleeding in transurethral prostatectomy (2023-05-30),

5. 11564673 - Delivery systems for control of gastrointestinal bleeding (2023-01-31),

6. 11234998 - Chitosan materials from carbonic acid solution (2022-02-01),

7. 11229724 - Biocompatible and bioabsorbable derivatized chitosan compositions (2022-01-25),

8. 11160901 - Bioadhesive chitosan gel for controlling bleeding and for promoting healing with scar reduction without obscuring or interfering with access to a surgical field (2021-11-02),

9. 10709817 - Biocompatible and bioabsorbable derivatized chitosan compositions (2020-07-14),

10. 10632143 - Chitosan materials from carbonic acid solution (2020-04-28),

11. 9925310 - Biocompatible and bioabsorbable derivatized chitosan compositions (2018-03-27),

12. 9925210 - Chitosan materials from carbonic acid solution (2018-03-27),

13. 9846163 - Biocompatible and bioabsorbable derivatized chitosan compositions (2017-12-19),

14. 9547011 - Biocompatible and bioabsorbable derivatized chitosan compositions (2017-01-17),

Tricol Biomedical, Inc. is a leading medical technology company specializing in the design, development, and manufacture of innovative hemostatic products. With a focus on enhancing patient outcomes, Tricol Biomedical has revolutionized the field of hemostasis through their proprietary platform technology. Their cutting-edge products are used in a variety of medical procedures to control bleeding quickly and effectively. With a commitment to quality and innovation, Tricol Biomedical continues to pave the way for advancements in hemostatic solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

14 Patents

#66 in Portland, OR

#217 in Oregon

#21,655 in US

#40,959 in the World

Portland, OR, United States of America

Tricol Biomedical, Inc.

Forward Citations = 36

18 inventors:

Simon J McCarthy (14 out of 29 patents)

Sam Kuhn (9 out of 9 patents)

Barbara McGrath (8 out of 9 patents)

4. Michael Stolten (8 out of 8 patents)

5. Amanda Bennett (8 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…